title: HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples.
abstract: Due to the rapidly increasing introduction of Haemophilus influenzae type b (Hib) and other conjugate vaccines worldwide during the last decade, reliable and robust analytical methods are needed for the quantitative monitoring of intermediate samples generated during fermentation (upstream processing, USP) and purification (downstream processing, DSP) of polysaccharide vaccine components. This study describes the quantitative characterization of in-process control (IPC) samples generated during the fermentation and purification of the capsular polysaccharide (CPS), polyribosyl-ribitol-phosphate (PRP), derived from Hib. Reliable quantitative methods are necessary for all stages of production; otherwise accurate process monitoring and validation is not possible. Prior to the availability of high performance anion exchange chromatography methods, this polysaccharide was predominantly quantified either with immunochemical methods, or with the colorimetric orcinol method, which shows interference from fermentation medium components and reagents used during purification. Next to an improved high performance anion exchange chromatography-pulsed amperometric detection (HPAEC-PAD) method, using a modified gradient elution, both the orcinol assay and high performance size exclusion chromatography (HPSEC) analyses were evaluated. For DSP samples, it was found that the correlation between the results obtained by HPAEC-PAD specific quantification of the PRP monomeric repeat unit released by alkaline hydrolysis, and those from the orcinol method was high (R(2)=0.8762), and that it was lower between HPAEC-PAD and HPSEC results. Additionally, HPSEC analysis of USP samples yielded surprisingly comparable results to those obtained by HPAEC-PAD. In the early part of the fermentation, medium components interfered with the different types of analysis, but quantitative HPSEC data could still be obtained, although lacking the specificity of the HPAEC-PAD method. Thus, the HPAEC-PAD method has the advantage of giving a specific response compared to the orcinol assay and HPSEC, and does not show interference from various components that can be present in intermediate and purified PRP samples.
authors.affiliation: Unit Product Development, Institute for Translational Vaccinology (Intravacc(1)), P.O. Box 450, 3720 AL Bilthoven, The Netherlands. Electronic address: robert.van.der.put@intravacc.nl.
authors.forename: Robert M F
authors.initials: RM
authors.lastname: van der Put
authors.affiliation: Unit Product Development, Institute for Translational Vaccinology (Intravacc(1)), P.O. Box 450, 3720 AL Bilthoven, The Netherlands.
authors.forename: Alex
authors.initials: A
authors.lastname: de Haan
authors.affiliation: Unit Product Development, Institute for Translational Vaccinology (Intravacc(1)), P.O. Box 450, 3720 AL Bilthoven, The Netherlands.
authors.forename: Jan G M
authors.initials: JG
authors.lastname: van den IJssel
authors.affiliation: Unit Product Development, Institute for Translational Vaccinology (Intravacc(1)), P.O. Box 450, 3720 AL Bilthoven, The Netherlands.
authors.forename: Ahd
authors.initials: A
authors.lastname: Hamidi
authors.affiliation: Unit Vaccinology, Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
authors.forename: Michel
authors.initials: M
authors.lastname: Beurret
mesh_terms: D001428:Bacterial Vaccines / Q000032:analysis* / Q000302:isolation & purification*; D002623:Chemistry Techniques, Analytical / Q000379:methods*; D002845:Chromatography / Q000379:methods*; D019741:Haemophilus influenzae type b / Q000737:chemistry*; D011134:Polysaccharides / Q000032:analysis* / Q000302:isolation & purification; D011135:Polysaccharides, Bacterial / Q000032:analysis* / Q000302:isolation & purification; D012680:Sensitivity and Specificity; D013678:Technology, Pharmaceutical / Q000379:methods
chemical_list: D001428:Bacterial Vaccines; D011134:Polysaccharides; D011135:Polysaccharides, Bacterial; C008984:polyribitol phosphate
keywords: Anion exchange chromatography; Bacterial polysaccharides analysis; Downstream processing; High pressure liquid chromatography; Polysaccharide; Upstream processing